Atlas Trials

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

Clinical trial NCT05560035 · UNKNOWN

Trial details

NCT number
NCT05560035
Sponsor
General Hospital of Ningxia Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cervical CancerMetastatic Cancer
Start date
2022-12-01
Primary completion
2024-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.